In last trading session, Bicara Therapeutics Inc (NASDAQ:BCAX) saw 0.59 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $14.47 trading at $0.0 or 0.00% at ring of the bell on the day assigns it a market valuation of $789.14M. That closing price of BCAX’s stock is at a discount of -94.13% from its 52-week high price of $28.09 and is indicating a premium of 38.42% from its 52-week low price of $8.91. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.62 million shares which gives us an average trading volume of 562.49K if we extend that period to 3-months.
Bicara Therapeutics Inc (NASDAQ:BCAX) trade information
Bicara Therapeutics Inc’s shares saw a change of -16.93% in year-to-date performance and have moved 11.57% in past 5-day. Bicara Therapeutics Inc (NASDAQ:BCAX) showed a performance of 23.04% in past 30-days. Number of shares sold short was 6.5 million shares which calculate 12.06 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 48 to the stock, which implies a rise of 69.85% to its current value. Analysts have been projecting 48 as a low price target for the stock while placing it at a high target of 48. It follows that stock’s current price would drop -231.72% in reaching the projected high whereas dropping to the targeted low would mean a loss of -231.72% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 42.87% while estimates for its earnings growth in next 5 years are of 11.95%.
Bicara Therapeutics Inc (NASDAQ:BCAX)’s Major holders
Insiders are in possession of 11.65% of company’s total shares while institution are holding 89.21 percent of that, with stock having share float percentage of 100.96%. Investors also watch the number of corporate investors in a company very closely, which is 89.21% institutions for Bicara Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Select Portfolios-Health Care Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 700.0 shares of worth $10.13 million or 1.28% of the total outstanding shares. The later fund manager was in possession of 636.55 shares on Dec 31, 2024 , making its stake of worth around $9.21 million in the company or a holder of 1.17% of company’s stock.
